The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Optimizing the sequence of biological agents in advanced colorectal cancer: A decision analysis.
Maria C. Riesco Martinez
No relevant relationships to disclose
Scott R. Berry
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Roche; Sanofi
Honoraria - Bristol-Myers Squibb; Roche
Yoo-Joung Ko
No relevant relationships to disclose
Kelvin Chan
No relevant relationships to disclose